Eluphor, 200 mg capsules 12 pcs

Nifuroxazide is a nitrofuran derivative with antimicrobial activity. Highly active against Campylobacter jejuni, Escherichia coli, Salmonella spp., Shigella spp.; Clostridium perfringens, Vibrio cholerae, pathogenic Vibrions and Vibrio parahaemolytique, Staphylococcus spp. Weakly sensitive to nifuroxazide: Citrobacter spp, Enterobacter cloacae, Proteus indologenes.
Resistant to nifuroxazide: Klebsiella spp, Proteus mirabilis, Providencia spp, Pseudomonas spp. Supposedly blocks dehydrogenase activity and inhibits respiratory chains, tricarboxylic acid cycle and a number of other biochemical processes in the microbial cell. It does not disturb the balance of intestinal microflora.
In acute bacterial diarrhea it restores intestinal eubiosis. In case of infection with enterotropic viruses it prevents the development of bacterial superinfection.

Pharmacokinetics
After oral administration nifuroxazide is practically not absorbed from the gastrointestinal tract and has no systemic action; 99% of the dose taken remains in the intestine and has its antimicrobial effect there. Nifuroxazide is excreted by the intestine: 20% in unchanged form and the remaining amount of nifuroxazide is chemically altered.

Indications

Active ingredient

How to take, the dosage

Interaction

Special Instructions

In case of bacterial diarrhea with signs of systemic damage (deterioration of general condition, increase in body temperature, symptoms of intoxication or infection) it is necessary to consult a doctor to decide on the use of antimicrobials of systemic action.
The daily dose of the preparation containing 800 mg contains 0.023 units.
Alcohol consumption is prohibited during the therapy with Eluphor.
If symptoms of allergic reactions occur (including shortness of breath, rash or itching) it is necessary to stop taking the drug and consult a physician.

The drug does not affect the ability to drive vehicles and mechanisms.

Contraindications

Side effects

Similarities